2514 related articles for article (PubMed ID: 24582757)
1. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
Blaauboer BJ
Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
[TBL] [Abstract][Full Text] [Related]
4. Pathway Based Toxicology and Fit-for-Purpose Assays.
Clewell RA; McMullen PD; Adeleye Y; Carmichael PL; Andersen ME
Adv Exp Med Biol; 2016; 856():205-230. PubMed ID: 27671724
[TBL] [Abstract][Full Text] [Related]
5. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
6. Toxicity testing in the 21st century: bringing the vision to life.
Andersen ME; Krewski D
Toxicol Sci; 2009 Feb; 107(2):324-30. PubMed ID: 19074763
[TBL] [Abstract][Full Text] [Related]
7. Toxicity testing in the 21st century: progress in the past decade and future perspectives.
Krewski D; Andersen ME; Tyshenko MG; Krishnan K; Hartung T; Boekelheide K; Wambaugh JF; Jones D; Whelan M; Thomas R; Yauk C; Barton-Maclaren T; Cote I
Arch Toxicol; 2020 Jan; 94(1):1-58. PubMed ID: 31848664
[TBL] [Abstract][Full Text] [Related]
8. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
Wetmore BA
Toxicology; 2015 Jun; 332():94-101. PubMed ID: 24907440
[TBL] [Abstract][Full Text] [Related]
9. Profiling dose-dependent activation of p53-mediated signaling pathways by chemicals with distinct mechanisms of DNA damage.
Clewell RA; Sun B; Adeleye Y; Carmichael P; Efremenko A; McMullen PD; Pendse S; Trask OJ; White A; Andersen ME
Toxicol Sci; 2014 Nov; 142(1):56-73. PubMed ID: 25078064
[TBL] [Abstract][Full Text] [Related]
10. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
[TBL] [Abstract][Full Text] [Related]
11. Computational systems biology and dose-response modeling in relation to new directions in toxicity testing.
Zhang Q; Bhattacharya S; Andersen ME; Conolly RB
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):253-76. PubMed ID: 20574901
[TBL] [Abstract][Full Text] [Related]
12. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment.
Meek ME; Lipscomb JC
Toxicology; 2015 Jun; 332():112-23. PubMed ID: 25598226
[TBL] [Abstract][Full Text] [Related]
13. Strategies and tools for preventing neurotoxicity: to test, to predict and how to do it.
Llorens J; Li AA; Ceccatelli S; Suñol C
Neurotoxicology; 2012 Aug; 33(4):796-804. PubMed ID: 22342764
[TBL] [Abstract][Full Text] [Related]
14. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
[TBL] [Abstract][Full Text] [Related]
15. Dose-response modeling of etoposide-induced DNA damage response.
Li Z; Sun B; Clewell RA; Adeleye Y; Andersen ME; Zhang Q
Toxicol Sci; 2014 Feb; 137(2):371-84. PubMed ID: 24241721
[TBL] [Abstract][Full Text] [Related]
16. Quantitative in vitro to in vivo extrapolation (QIVIVE): An essential element for in vitro-based risk assessment.
Yoon M; Blaauboer BJ; Clewell HJ
Toxicology; 2015 Jun; 332():1-3. PubMed ID: 25680635
[No Abstract] [Full Text] [Related]
17. Toxicity testing in the 21st century: how will it affect risk assessment?
Rhomberg LR
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
[TBL] [Abstract][Full Text] [Related]
18. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations.
Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI
Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460
[TBL] [Abstract][Full Text] [Related]
19. Toxicity testing in the 21st century: implications for human health risk assessment.
Krewski D; Andersen ME; Mantus E; Zeise L
Risk Anal; 2009 Apr; 29(4):474-9. PubMed ID: 19144067
[TBL] [Abstract][Full Text] [Related]
20. Current standing and future prospects for the technologies proposed to transform toxicity testing in the 21st century.
van Vliet E
ALTEX; 2011; 28(1):17-44. PubMed ID: 21311848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
